Antimicrobial activity of β-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 3, 2003, Pages 291-300

  Athanassiou, G ^b   Michaleas, S ^a   Lada Chitiroglou, E ^b   Tsitsa, T ^a   Antoniadou Vyza, E ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA CYCLODEXTRIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFADROXIL; CEFOTAXIME; CEFTAZIDIME; CELL RECEPTOR; CYCLODEXTRIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BACTERIAL STRAIN; CELL TRANSPORT; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SCREENING; GRAM NEGATIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE INTENSIFIER; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DEUTERIUM OXIDE; DRUG RESISTANCE, BACTERIAL; DRUG STABILITY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS;

EID: 0347294728     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702649     Document Type: Article

References (42)

1. Antoniadou-Vyza, E., Tsitsa, P., Theodoropoulou, E., Mavromoustakos, T. (1996) Complexation of new active antibacterial adamantan derivatives with βCD: Preparation and characterization of complexes. Study of the thermotropic properties of pure and complex form with dipalmitoyl phosphatidylcholine bilayers. J. Inclus. Phenom. 25: 161-164
2. Ash, C. (1996) Antibiotic resistance: The new apocalypse? Trends Microbiol. 4: 371-372
3. Atanasov, P. B., Mustafi, D., Makinen, M. (2000) Protonation of the β-lactam nitrogen is the trigger event in the catalytic action of class A β-lactamases. Proc. Natl. Acad. Sci. USA 97: 3160-3165
4. Attioui, F., Al-Oman, A., Laray, E., Parrot-Lopez, H., Finance, C., Bonaly, R. (1994) Recognition ability and cytotoxicity of some oligosacharidyl substituted β-cyclodextrins. Biol. Cell. 82: 161-167
5. Balderman, C., Lupas, A., Lubieniecki, J., Engelhardt, H. (1998) The regulated outer membrane protein Omp21 from Comamonas acidovorans is identified as a member of a new family of eight-stranded b-sheet proteins by its sequence and properties. J. Bacteriol. 180: 3741-3749
6. Bennett, P. M., Chopra, I. (1993) Molecular basis of β-lactamase induction in bacteria. Antimicrob. Agents Chemother. 37: 153-158
7. Boos, W., Shuman, H. (1998) Maltose/Maltodextrin system of Escherichia coli: Transport, metabolism, and regulation. Microbiol. Mol. Biol. Rev. 62: 204-229
8. Böck, A., Fiedler, G., Pajatsch, M. (1996) Genetics of a novel utilisation pathway present in Klebsiella oxytoca. J. Mol. Biol. 256: 279-291
9. Castelli, F., Puglisi, G., Pinatello, R., Gurrieri, S. (1989) Calorimetric studies of 4-biphenylactic acid and its β-cyclodextrin inclusion compound with lipid model membrane. Int. J. Pharm. 52: 115-121
10. Crichlow, G. V., Nukaga, M., Doppalapudi, V. R., Buynak, J. D., Knox, J. R. (2001) Inhibition of class C β-lactamases: Structure of a reaction intermediate with a cephem sulfone. Biochemistry 40: 6233-6239
11. Daniel, A. F., Cheung, J., Ito, C., Sugawara, E., Nikaido, H., Mirsa, R. (1998) Biochemistry and regulation of a novel Escherichia coli K-12 porin protein, OmpG, which produces unusually large channels. J. Bacteriol. 180: 4452-4459
12. Gazouli, M., Tzouvelekis, L. S., Vatopoulos, A. C., Tzelepi, E. (1998) Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzymes variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase. J. Antimicrob. Chemother. 42: 419-425
13. Giakkoupi, P., Tzelepi E., Legakis, N. J., Tzouvelekis, L. S. (1999) Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 β-lactamases. J. Antimicrob. Chemother. 43: 23-29
14. Giakkoupi, P., Tzouvelekis, L., Tsakris, A., Loukova, V., Sofianou, D., Tzelepi, E. (2000) IBC-1, a novel integron-associated class A β-lactamase with extended-spectrum properties produced by an Entorobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44: 2247-2253
15. Grosse, P. Y., Bressolle, F., Pinguet, F. (1997) Methyl-β-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: Effect on the cytotoxic activity and intracellular accumulation of doxorubicin. Cancer Chemother. Pharmacol. 40: 489-494
16. Henderson I. R., Navarro-Garcia, F., Natano, J. P. (1998) The great escape: Structure and function of the autotransporter proteins. Trends Microbiol. 6: 370-378
17. Heritage, J., M'Zali, F. H., Gascoyne-Binzi, D., Hawkey, P. M. (1999) Evolution and spread of SHV extended-spectrum β-lactamases in gram-negative bacteria. J. Antimicrob. Chemother. 44: 309-318
18. Kamionka, A., Dahl, M. K. (2001) Bacillus subtilis contains a cyclodextrin-binding protein which is part of a putative ABC-transporter. FEMS Microbiol. Lett. 204: 55-60
19. Knox, J. (1995) Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: Mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother 39: 2593-2601
20. Labia, R., Chaïbi, E. B., Sirot, D., Paul, G. (1999) Inhibitor-resistant TEM β-lactamases: Phenotypic, genetic, and biochemical characteristics. J. Antimicrob. Chemother. 43: 447-458
21. Lamotte-Brasseur, J., Dive, G., Dideberg, O., Charlier, P., Frere, J. M., Ghuysen, J. M. (1991) Mechanism of acyl transfer by the class A serine beta-lactamase of Streptomyces albus G. Biochem. J. 279: 213-221
22. Lamotte-Brasseur, J., Jacob-Dubuisson, F., Dive, G., Frere, J.M., Ghuysen, J. M. (1992) Streptomyces albus G serine beta-lactamase. Probing of the catalytic mechanism via molecular modelling of mutant enzymes. Biochem. J. 282: 189-195
23. Livermore, D. (1995) β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584
24. Masaji, I., Seiichi, I. (1996) Modeling study on hydrolytic mechanism of class A β-lactamases. J. Med. Chem. 39: 2207-2218
25. Matagne, A., Lamote-Brasseur, J., Frere, J. M. (1998) Catalytic properties of class A β-lactamases: Efficiency and diversity. Biochem. J. 330: 581-598
26. Matsumura, N., Minami, S., Watanabe, Y., Yiyobe, S., Mitsuhashi, A. (1999) Role of permeability in the activities of β-lactams against gram-negative bacteria which produce a group 3 β-lactamase. Antimicrob. Agents Chemother. 43: 2084-2086
27. Mavromoustakos, T., Papadopoulos, A., Theodoropoulos, E., Dimitriou, C., Andoniadou-Viza, E. (1998) Thermal properties of adamantanol derivative and their β-cyclodextrin complexes in phosphatidylcholine bilayers. Life Sci. 62: 1901-1910
28. National Committee for Clinical Laboratory Standards (1993) Methods for Dilution: Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard. NCCLS Document M7-A3. National Committee for Clinical Laboratory Standards, Villanova, PA
29. Neu, H. C. (1992) The crisis in antibiotic resistance. Science 257: 1064-1073
30. Nikaido, H., Normark, S. (1987) Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamses: A quantitative predictive treatment. Mol. Microbiol. 1: 29-36
31. Pajatsch, M., Gerhart, M., Peist, R., Horlacher, R., Boos, W., Böck, A. (1998) The periplasmic cyclodextrin binding protein CymE from Klebsiella oxytoca and its role in maltodextrin and cyclodextrin transport. J. Bacteriol. 180: 2630-2635
32. Pajatsch, M., Andersen, C., Mathes, A., Böck, A., Benz, R., Engelhardt, H. (1999) Properties of a cyclodextrin-specific unusual porin from Klebsiella oxytoca. J. Biol. Chem. 274: 25159-25166
33. Parrot-Lopez, H., Leray, E., Coleman, A. W. (1991) New β-cyclodextrin derivatives possessing biologically active saccharide antennae. Supramol. Chem. 3: 37-42
34. Perly, B. Djedaïni, F. Berthauld, D. (1991) Novel one- and two-dimensional nuclear magnetic resonance techniques for ultra-high resolution analysis of cyclodextrin derivatives. In: Duchêne, D. (ed.) New Trends in Cyclodextins and Derivatives. Editions de Santép, Paris, pp 179-246
35. Rolinson, G. N. (1998) Fourty years of β-lactam research. J. Antimicrob. Chemother. 41: 589-603
36. Schmidt, A., Cottaz, S., Driguez, H., Schulz, G. (1998) Structure of cyclodextrin glycosyltransferase complexed with a derivative of its main product β-cyclodextrin. Biochemistry 37: 5909-5915
37. Schoichet, B., Trehan, I., Beadle, B. (2001) Inhibition of AmpC β-lactamse through a destabilizing interaction in the active site. Biochemistry 40: 7992-7999
38. Szente, L., Szejtli, J. (1999) Highly soluble cyclodextrin derivatives: Chemistry, properties and trends in development. Adv. Drug Deliv. Rev. 36: 17-28
39. Tzouvelekis, L. S., Tzelepi, E., Tassios, P. T., Legakis, N. J. (2000) CTX-M-type β-lactamses: An emerging group of extended-spectrum enzymes. Int. J. Antimicrob. Agents 14: 137-142
40. Uekama, K., Hirayama, F., Irie, T. (1998) Cyclodextrin drug carrier systems. Chem. Rev. 98: 2045-2076
41. Yoshimura, F., Nakaido, H. (1985) Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob. Agents Chemother. 27: 84-92
42. Zimmerman, W., Rosselet, A. (1977) Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob. Agents Chemother. 12: 368-372